TKG Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,247
| Closed | -$548K | – | 94 |
|
|
2024
Q4 | $548K | Buy |
1,247
+623
| +100% | +$274K | 0.25% | 58 |
|
|
2024
Q3 | $290K | Sell |
624
-16
| -3% | -$7.44K | 0.14% | 83 |
|
|
2024
Q2 | $300K | Sell |
640
-119
| -16% | -$55.8K | 0.16% | 79 |
|
|
2024
Q1 | $317K | Sell |
759
-14
| -2% | -$5.85K | 0.18% | 81 |
|
|
2023
Q4 | $315K | Sell |
773
-134
| -15% | -$54.5K | 0.19% | 73 |
|
|
2023
Q3 | $315K | Buy |
907
+5
| +0.6% | +$1.74K | 0.21% | 75 |
|
|
2023
Q2 | $317K | Sell |
902
-451
| -33% | -$159K | 0.21% | 73 |
|
|
2023
Q1 | $426K | Buy |
1,353
+1
| +0.1% | +$315 | 0.27% | 59 |
|
|
2022
Q4 | $390K | Buy |
+1,352
| New | +$390K | 0.26% | 64 |
|